세계의 수두증 션트 시장 2024-2030 : 제품별 (밸브, 카테터), 최종 용도별 (병원, 외래 수술 센터), 지역별

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Age group outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Hydrocephalus Shunts Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increase in number of patients suffering from hydrocephalus
3.4.1.2. Advancements in shunt technology
3.4.1.3. Growing healthcare awareness
3.4.2. Market restraint analysis
3.4.2.1. Complex regulatory framework
3.5. Hydrocephalus Shunts Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Hydrocephalus Shunts Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Valves
4.1.2. Catheter
4.2. Product Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Hydrocephalus Shunts Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Valves
4.5.1.1. Valves market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Catheter
4.5.2.1. Catheter market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Hydrocephalus Shunts Market: End Use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Ambulatory Surgical Centers
5.2. End Use Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Hydrocephalus Shunts Market by End-Use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Ambulatory Surgical Centers
5.5.2.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Hydrocephalus Shunts Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2023
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Age Group, & Forecasts and Trend Analysis, 2018 to 2030
6.6. North America
6.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 – 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 – 2030
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Competitive scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. UK market estimates and forecasts, 2018 – 2030
6.7.2. Germany
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Germany market estimates and forecasts, 2018 – 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 – 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 – 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 – 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 – 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 – 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 – 2030
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Competitive scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Japan market estimates and forecasts, 2018 – 2030
6.8.2. India
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. India market estimates and forecasts, 2018 – 2030
6.8.3. China
6.8.3.1. Key country dynamics
6.8.3.2. Competitive scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. China market estimates and forecasts, 2018 – 2030
6.8.4. South Korea
6.8.4.1. Key country dynamics
6.8.4.2. Competitive scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. South Korea market estimates and forecasts, 2018 – 2030
6.8.5. Australia
6.8.5.1. Key country dynamics
6.8.5.2. Competitive scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Australia market estimates and forecasts, 2018 – 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 – 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 – 2030
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Mexico market estimates and forecasts, 2018 – 2030
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Competitive scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Argentina market estimates and forecasts, 2018 – 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 – 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 – 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.3.5. UAE market estimates and forecasts, 2018 – 2030
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Competitive scenario
6.10.4.3. Regulatory framework
6.10.4.4. Reimbursement scenario
6.10.4.5. Kuwait market estimates and forecasts, 2018 – 2030
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Aesculap, Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Spiegelberg GmbH & Co. KG.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Integra LifeSciences
7.3.7.1. Company overview
. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Sophysa
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. CHRISTOPH MIETHKE GMBH & CO. KG
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Hpbio
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. G. Surgiwear Ltd
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Bicakcilar
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives